94 related articles for article (PubMed ID: 198317)
1. [Characteristics of viruses multiplying in cell lines in suspension and their correspondent vaccines].
Roulet C; Favre H; Mougeot H; Brun A; Fargeaud D; Dubouclard C
Dev Biol Stand; 1976; 35():79-90. PubMed ID: 198317
[TBL] [Abstract][Full Text] [Related]
2. [Several criteria of evaluation of foot-and-mouth disease virus reproduced in cell cultures in suspension].
Girard HC
Dev Biol Stand; 1976; 35():91-6. PubMed ID: 71255
[TBL] [Abstract][Full Text] [Related]
3. [Attempts to adapt BNK cells to cultivation in suspension and study of the antigenic properties of foot-and-mouth diseases viruses obtained from them].
Mitev G; Tekerlekov P; Nikolova E
Vet Med Nauki; 1976; 13(7):91-5. PubMed ID: 189487
[TBL] [Abstract][Full Text] [Related]
4. [Safety of foot-and-mouth disease vaccines in cell cultures].
Tekerlekov P; Dilovski M; Gergov P; Nikolova E
Vet Med Nauki; 1982; 19(1):21-5. PubMed ID: 6287707
[TBL] [Abstract][Full Text] [Related]
5. [Methods of testing of safety of the anti-foot-and-mouth disease vaccine].
Dannacher G; Fédida M; Coudert M; Perrin M
Dev Biol Stand; 1976; 35():271-8. PubMed ID: 198294
[TBL] [Abstract][Full Text] [Related]
6. The use of suspension cultures for FMD vaccine production. Criteria for the evaluation of cells, virus and vaccine.
Nardelli L; Panina GF
Dev Biol Stand; 1976; 35():9-25. PubMed ID: 198318
[TBL] [Abstract][Full Text] [Related]
7. One year experience on the Lindholm B medium used in large--scale FMD virus production on BHK cells in suspension.
Jensen MH; Soerensen FO
Dev Biol Stand; 1976; 35():45-53. PubMed ID: 198312
[TBL] [Abstract][Full Text] [Related]
8. Immunogenic quality of foot-and-mouth disease virus.
Strobbe R
Dev Biol Stand; 1976; 35():311-21. PubMed ID: 198301
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the immunologic properties of foot-and-mouth disease vaccines].
Tekerlekov P; Gergov P; Nikolova E
Vet Med Nauki; 1982; 19(3):29-34. PubMed ID: 6291225
[No Abstract] [Full Text] [Related]
10. [Comparative trial of the immunogenic properties of commercial foot-and-mouth virus strains].
Tekerlekov P; Nikolova E
Vet Med Nauki; 1981; 18(1):19-26. PubMed ID: 6272473
[TBL] [Abstract][Full Text] [Related]
11. Serological study of type A Indian foot-and-mouth disease virus isolates.
Meer Azad H; Srinivasan VA; Crowther JR
Acta Virol; 1995 Sep; 39(4):193-6. PubMed ID: 8825299
[TBL] [Abstract][Full Text] [Related]
12. [Combined method (suspension-monolayer) of preparing an inactivated foot-and-mouth disease vaccine].
Genov I; Tivchev G; Veleva E; Tekerlekov P; Shopov I
Vet Med Nauki; 1981; 18(5):57-63. PubMed ID: 6275604
[TBL] [Abstract][Full Text] [Related]
13. Innocuity testing of foot-and-mouth disease vaccines. II. Aziridine-inactivated antigen produced in baby hamster kidney cells.
Barteling SJ
J Biol Stand; 1983 Oct; 11(4):305-12. PubMed ID: 6315737
[TBL] [Abstract][Full Text] [Related]
14. Some problems of testing foot-and-mouth disease vaccines. I. Innocuity testing.
Soós T
Acta Vet Hung; 1987; 35(3):319-30. PubMed ID: 2829601
[No Abstract] [Full Text] [Related]
15. Large-scale cultivation of animal cells in roller bottles for production of decigram amounts of pure foot-and-mouth disease virus.
Bachrach HL
Natl Cancer Inst Monogr; 1968 Dec; 29():73-9. PubMed ID: 4305442
[No Abstract] [Full Text] [Related]
16. [The efficacy of foot and mouth disease vaccines after long- term storage].
Wittmann G
Berl Munch Tierarztl Wochenschr; 1980 Jan; 93(2):33-4. PubMed ID: 6248022
[No Abstract] [Full Text] [Related]
17. Diagnosis of persistent aphthovirus infection and its differentiation from vaccination response in cattle by use of enzyme-linked immunoelectrotransfer blot analysis with bioengineered nonstructural viral antigens.
Bergmann IE; de Mello PA; Neitzert E; Beck E; Gomes I
Am J Vet Res; 1993 Jun; 54(6):825-31. PubMed ID: 8391765
[TBL] [Abstract][Full Text] [Related]
18. Quantitative risk analysis applied to innocuity and potency tests on the oil-adjuvanted vaccine against foot and mouth disease in Argentina.
Cané BG; Rodríguez Toledo J; Falczuk A; Leanes LF; Manetti JC; Maradei E; Verde P
Rev Sci Tech; 1995 Dec; 14(4):1097-119. PubMed ID: 8639949
[TBL] [Abstract][Full Text] [Related]
19. [Comparatve serological and immunological study of strains of foot-and-mouth disease virus type "O" isolated in Europe between 1963 and 1966].
Moosbrugger GA; Leunen J; Mackowiak C; Fontaine J; Roumiantzeff M
Bull Off Int Epizoot; 1967; 67(5):711-29. PubMed ID: 4303616
[No Abstract] [Full Text] [Related]
20. Some problems of testing foot-and-mouth disease vaccines. II. Potency testing.
Soós T
Acta Vet Hung; 1987; 35(3):331-42. PubMed ID: 2829602
[No Abstract] [Full Text] [Related]
[Next] [New Search]
